对eEF1A1/ARID3A/PKC-δ复合体通过神经蛋白的干扰抑制了动脉样硬化中的巨细胞甘油性重编程

Baoping Xie1,2, Li-Wen Tian3, Chenxu Liu1

  • 1State Key Laboratory of Traditional Chinese Medicine Syndrome, Key Laboratory for Translational Cancer Research of Chinese Medicine, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.

概括

尼费林针对真核延长因子1A1 (eEF1A1) 抑制巨细胞的糖分重编程,为动脉样硬化 (AS) 提供了一种新的治疗策略. 这种方法破坏了ARID3A/ENO2通路,这对于斑块形成至关重要.